Quarterly report pursuant to Section 13 or 15(d)

Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details)

v3.21.1
Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis $ 755,487 $ 755,487
Gross Unrealized Gains 1,375,700 1,160,964
Value 2,131,187 1,916,451
Common Stock    
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis 755,487 755,487
Gross Unrealized Gains 1,375,700 1,160,964
Value $ 2,131,187 $ 1,916,451